<DOC>
	<DOCNO>NCT00945763</DOCNO>
	<brief_summary>To evaluate safety efficacy single IV dose N1539 dental impaction surgery .</brief_summary>
	<brief_title>Single Dose Study N1539 Treatment Pain Secondary Dental Impaction Surgery</brief_title>
	<detailed_description>This randomize , double-blind , placebo-controlled , single center study subject undergone third molar extraction surgery . Eligible subject surgical removal &gt; 2 third molar , least 1 must complete partial mandibular impaction . Each subject 's study participation consist screen visit ( 1-21 day prior surgery ) , inpatient evaluation period 24 hour follow dosing , follow-up phone call 3-5 day postdose .</detailed_description>
	<mesh_term>Toothache</mesh_term>
	<mesh_term>Tooth , Impacted</mesh_term>
	<mesh_term>Meloxicam</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>surgical extraction &gt; 2 third molar least 1 complete partial mandibular bony extraction allergic response aspirin , NSAIDs , acetaminophen hydrocodone use aspirin analgesic within 48 hour prior surgery current recent history drug alcohol abuse medication treatment chronic pain clinically significant abnormality screen laboratory test active recent history peptic ulcer disease GI bleed prior abdominal surgery , except uncomplicated appendectomy surgical procedure within 30 day administration study drug pregnancy breastfeed untreated hypertension ; SBP &gt; 140 mmHg DBP &gt; 95 mmHg</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Dental Pain</keyword>
</DOC>